• Explore /
  • Poster
  • / A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.

A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.

Abstract Poster

Authors

Heather McArthur

Heather L. McArthur

University of Texas Southwestern Medical Center, Dallas, TX

Heather L. McArthur , Elizabeth Anne Comen , Yolanda Bryce , Stephen Barnett Solomon , Jorge Henrique S. Leal , Christina DiLauro Abaya , Cristal Martinez , Reva K Basho , Dorothy J. Park , Philomena McAndrew , Brigid Larkin , William Mills , David B. Page , Staci L. Mellinger , Nicole Fredrich , Nicole Moxon , Sangeetha M. Reddy , Meredith Carter , Sujata Patil , Larry Norton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Local-Regional Therapy

Clinical Trial Registration Number

NCT03546686

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS617)

DOI

10.1200/JCO.2022.40.16_suppl.TPS617

Abstract #

TPS617

Poster Bd #

383a

Abstract Disclosures

Similar Posters

First Author: Heather L. McArthur

First Author: Sherene Loi

First Author: Minke W. Lucas

First Author: Rohit K. Jain